Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Descriptive review and evaluation of the functioning of the International Health Regulations (IHR) Annex 2.
Anema A, Druyts E, Hollmeyer HG, Hardiman MC, Wilson K.
Global Health. 2012 Jan 10;8:1.
Related citations
[The surveillance of communicable diseases within the International Health Regulations (2005)].
Kicman-Gawłowska A.
Przegl Epidemiol. 2008;62(4):739-49. Polish.
Final Report on Carcinogens Background Document for Formaldehyde.
National Toxicology Program.
Rep Carcinog Backgr Doc. 2010 Jan;(10-5981):i-512.
Detection of events of public health importance under the international health regulations: a toolkit to improve reporting of unusual events by frontline healthcare workers.
MacDonald E, Aavitsland P, Bitar D, Borgen K.
BMC Public Health. 2011 Sep 21;11:713. Review.
The new International Health Regulations: a revolutionary change in global health security.
Baker MG, Forsyth AM.
N Z Med J. 2007 Dec 14;120(1267):U2872. Review.
Strengthening the International Health Regulations: lessons from the H1N1 pandemic.
Wilson K, Brownstein JS, Fidler DP.
Health Policy Plan. 2010 Nov;25(6):505-9. Epub 2010 Jul 1.
Assessment of core capacities for the International Health Regulations (IHR[2005])--Uganda, 2009.
Wamala JF, Okot C, Makumbi I, Natseri N, Kisakye A, Nanyunja M, Bakamutumaho B, Lutwama JJ, Sreedharan R, Xing J, Gaturuku P, Aisu T, Da Silveira F, Chungong S.
BMC Public Health. 2010 Dec 3;10 Suppl 1:S9.
Final Report on Carcinogens Background Document for Styrene.
Rep Carcinog Backgr Doc. 2008 Sep;(8-5978):i-398.
Risk management frameworks for human health and environmental risks.
Jardine C, Hrudey S, Shortreed J, Craig L, Krewski D, Furgal C, McColl S.
J Toxicol Environ Health B Crit Rev. 2003 Nov-Dec;6(6):569-720. Review.
The revised International Health Regulations: a framework for global health security.
Hardiman M.
Int J Antimicrob Agents. 2003 Feb;21(2):207-11.
Comparative effectiveness research: Challenges for medical journals.
Sox HC, Helfand M, Grimshaw J, Dickersin K, Tovey D, Knottnerus JA, Tugwell P.
Cochrane Database Syst Rev. 2010 Apr 27;8:ED000003.
The new International Health Regulations: considerations for global public health surveillance.
Sturtevant JL, Anema A, Brownstein JS.
Disaster Med Public Health Prep. 2007 Nov;1(2):117-21.
[Procedures and methods of benefit assessments for medicines in Germany].
Bekkering GE, Kleijnen J.
Dtsch Med Wochenschr. 2008 Dec;133 Suppl 7:S225-46. Epub 2008 Nov 25. German.
Procedures and methods of benefit assessments for medicines in Germany.
Eur J Health Econ. 2008 Nov;9 Suppl 1:5-29.
Implementing the International Health Regulations (2005) in Europe.
Rodier G, Hardiman M, Plotkin B, Ganter B.
Euro Surveill. 2006;11(12):208-11. Review.
Global public health surveillance under new international health regulations.
Baker MG, Fidler DP.
Emerg Infect Dis. 2006 Jul;12(7):1058-65.
[Surveillance under the International Health Regulations (2005)].
Hollmeyer H, Eckmanns T, Krause G.
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2009 Feb;52(2):168-75. German.
[National IHR Focal Point].
Przegl Epidemiol. 2009;63(1):143-7. Polish.
Implementing the new International Health Regulations in the Pacific--challenges and opportunities.
Oshitani H, Ailan L, Roces MC, Sian DT, Ken C, Kiedrzynski T.
Pac Health Dialog. 2005 Sep;12(2):135-43.
Comparative analysis of national legislation in support of the revised international health regulations: potential models for implementation in the United States.
Katz R, Kornblet S.
Am J Public Health. 2010 Dec;100(12):2347-53. Epub 2010 Oct 21.
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on